Fibrous Polymers for the Delivery of Contraceptive Steroids to the Female Reproductive Tract

  • Richard L. Dunn
  • Danny H. Lewis
  • Lee R. Beck
Chapter

Abstract

Research and development on the application of controlled-release technology to fertility regulation was initiated in the late 1960s and has been accelerated in recent years.1’2 Since sustained-release doses obviate the problem of cyclic overdosing and underdosing associated with the conventional administration of steroids, the technology, in principle, affords a means of effecting an optimum pharmacological response with a minimum dose of exogenous steroid.3 Depending upon the half-life of the drug in plasma, the duration of the dose regimen, and the route of administration, the total dose can be reduced to 1/100 or less for continuous versus intermittant delivery.

Keywords

Female Reproductive Tract Contraceptive Steroid Sheath Thickness Polyethylene Fiber Core Matrix 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    G.W. Duncan and D.R. Kalkwarf, in: “Human Reproduction: Conception and Contraception,” E.S.E. Hafez and T.N. Evans, eds., Harper and Row, New York, (1975). pp. 483–503.Google Scholar
  2. 2.
    H.L. Gabelnick, ed., “Drug Delivery Systems,” Workshop Sponsored by NICHD, Bethesda, Maryland, August 2–3, (1976).Google Scholar
  3. 3.
    D.R. Cowsar, in: “Controlled Release of Biologically Active Agents,” A.C. Tanquary and R.E. Lacey, eds., Plenum Press, New York, (1974). pp. 1–13.CrossRefGoogle Scholar
  4. 4.
    L.R. Beck, D.R. Cowsar, and V.Z. Pope, Research Frontiers in Fertility Regulation 1 (1): 1 (1980).PubMedGoogle Scholar
  5. 5.
    J. Newton and J. McEwan, Fertil. Contracept. 1: 35 (1977).Google Scholar
  6. 6.
    M. Haefeli, W. Zodraw, U.S. Spornitz, K.S. Ludwig, and A. Wetwillor, in: “Medicated IUDs and Polymeric Delivery Ststems: International Symposium,” E.S.E. Hafez and W. Van Os, eds., Abstract 3, June 27–30 (1979).Google Scholar
  7. 7.
    H.J. Tatum, Fertility and Sterility 28 (1): 3 (1977).PubMedGoogle Scholar
  8. 8.
    B.B. Pharris and P. Rowe, in: “Medicated IUDs and Polymeric Delivery Systems: International Symposium,” E.S.E. Hafez and W. Van Os, eds., Abstract 4, June 27–30 (1979).Google Scholar
  9. 9.
    C.G. Nilsson, in: “Medicated IUDs and Polymeric Delivery Systems: International Symposium,” E.S.E. Hafez and W. Van Os, eds., Abstract 7, June 27–30 (1979).Google Scholar
  10. 10.
    P.T. Piotrow, W. Rinehart, and J.C. Schmidt, Population Reports, Series B, No. 3 (1979).Google Scholar
  11. 11.
    W. Droegemuller and R. Bressler, Ann. Rev. Med. 31: 329 (1980).CrossRefGoogle Scholar
  12. 12.
    H.W. Rudel, F.A. Kind, afld M.R. Henzl, in: “Birth Control-Contraception and Abortion,” H.W. Rudel, F.A. Kind, and M.R. Henzl, eds., Macmillan Company, New York, (1973). pp. 154185.Google Scholar
  13. 13.
    R.W. Baker and H.K. Lonsdale, in: “Controlled Release of Biologically Active Agents,” A.C. Tanugary and R.E. Lacey, eds., Plenum Press, New York (1975). pp. 15–71.Google Scholar
  14. 14.
    D.H. Lewis and D.R. Cowsar, in: “Controlled Release Pesticides,” H.B. Scher, ed., American Chemical Society. ACS Symposium Series, No. 53 (1977). pp. 1–16.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1981

Authors and Affiliations

  • Richard L. Dunn
    • 1
  • Danny H. Lewis
    • 1
  • Lee R. Beck
    • 2
  1. 1.Southern Research InstituteBirminghamUSA
  2. 2.Department of Obstetrics and GynecologyUniversity of Alabama in BirminghamBirminghamUSA

Personalised recommendations